Pharmacy
The UnitedHealth Group subsidiary is working with the drugmaker to offer a 30-day supply of commonly used insulins for $35.
CMS anticipates releasing the 2023 premium and cost-sharing information for 2023 Medicare Advantage and Part D plans in September.
Equitable Breakthroughs in Medicine Development will get more underrepresented patients involved in the R&D of medical treatments.
The new order will begin arriving at the SNS in 2023, bringing the available supply of vaccine to treat monkeypox to nearly 7 million doses.
UHC frames the move as a push to reduce the burden of medical costs for consumers and to encourage better medication adherence.
The administration said this week that pharmacies are prohibited under law from discriminating based on race, sex, age and disability.
Upon EUA, it will be made available free to states, jurisdictions, federal pharmacy partners and federally qualified health centers.
The newly-signed state budget sets aside $100 million for the development and manufacture of low-cost insulin products.
State-licensed pharmacists will still be advised to refer the patient to a physician if there isn't enough info on potential drug interactions.
Under the legislation, HHS would select 10 drugs eligible for negotiation in 2026, with the number of drugs increasing in subsequent years.